ASCL1 and central nervous system cancer: The oncogenic environments of high grade GBM and lower grade gliomas are enriched for active Serine–Proline-directed kinases, such as CDKs22,23, which would maintain ASCL1 in a highly phosphorylated form in GBM cells.